NEPH: Nephros, Inc. - Summary | Jitta

Nephros, Inc.

NASDAQ:NEPH

Price
$4.38
Loss Chance
46.3%
4.95JITTA SCORE
20.41%Over Jitta Line
Jitta Ranking
13 / 120
80 / 684
678 / 4,232
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (62)
Recent Business Performance (54)
Financial Strength (62)
Return to Shareholders (17)
Competitive Advantage (56)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2023
Operating MarginInconsistent
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.95
20.41%
4.70
188.83%
4.15
450.24%
Industrial Machinery and Supplies and Components
6.91
20.55%
5.83
6.68%
3.81
94.68%
COMPANY DESCRIPTION
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.